Literature DB >> 23852082

Peptide-based identification of functional motifs and their binding partners.

Martin N Shelton1, Ming Bo Huang, Syed Ali, Kateena Johnson, William Roth, Michael Powell, Vincent Bond.   

Abstract

Specific short peptides derived from motifs found in full-length proteins, in our case HIV-1 Nef, not only retain their biological function, but can also competitively inhibit the function of the full-length protein. A set of 20 Nef scanning peptides, 20 amino acids in length with each overlapping 10 amino acids of its neighbor, were used to identify motifs in Nef responsible for its induction of apoptosis. Peptides containing these apoptotic motifs induced apoptosis at levels comparable to the full-length Nef protein. A second peptide, derived from the Secretion Modification Region (SMR) of Nef, retained the ability to interact with cellular proteins involved in Nef's secretion in exosomes (exNef). This SMRwt peptide was used as the "bait" protein in co-immunoprecipitation experiments to isolate cellular proteins that bind specifically to Nef's SMR motif. Protein transfection and antibody inhibition was used to physically disrupt the interaction between Nef and mortalin, one of the isolated SMR-binding proteins, and the effect was measured with a fluorescent-based exNef secretion assay. The SMRwt peptide's ability to outcompete full-length Nef for cellular proteins that bind the SMR motif, make it the first inhibitor of exNef secretion. Thus, by employing the techniques described here, which utilize the unique properties of specific short peptides derived from motifs found in full-length proteins, one may accelerate the identification of functional motifs in proteins and the development of peptide-based inhibitors of pathogenic functions.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23852082      PMCID: PMC3729443          DOI: 10.3791/50362

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  20 in total

Review 1.  Pathogenic mechanisms of HIV disease.

Authors:  Susan Moir; Tae-Wook Chun; Anthony S Fauci
Journal:  Annu Rev Pathol       Date:  2011       Impact factor: 23.472

Review 2.  Cataloguing the HIV type 1 human protein interaction network.

Authors:  Roger G Ptak; William Fu; Brigitte E Sanders-Beer; Jonathan E Dickerson; John W Pinney; David L Robertson; Mikhail N Rozanov; Kenneth S Katz; Donna R Maglott; Kim D Pruitt; Carl W Dieffenbach
Journal:  AIDS Res Hum Retroviruses       Date:  2008-12       Impact factor: 2.205

3.  Secretion modification region-derived peptide disrupts HIV-1 Nef's interaction with mortalin and blocks virus and Nef exosome release.

Authors:  Martin N Shelton; Ming-Bo Huang; Syed A Ali; Michael D Powell; Vincent C Bond
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

4.  Plasma cytokine levels during acute HIV-1 infection predict HIV disease progression.

Authors:  Lindi Roberts; Jo-Ann S Passmore; Carolyn Williamson; Francesca Little; Lisa M Bebell; Koleka Mlisana; Wendy A Burgers; Francois van Loggerenberg; Gerhard Walzl; Joel F Djoba Siawaya; Quarraisha Abdool Karim; Salim S Abdool Karim
Journal:  AIDS       Date:  2010-03-27       Impact factor: 4.177

5.  Dissociation of the signalling and antiviral properties of SDF-1-derived small peptides.

Authors:  N Heveker; M Montes; L Germeroth; A Amara; A Trautmann; M Alizon; J Schneider-Mergener
Journal:  Curr Biol       Date:  1998-03-26       Impact factor: 10.834

6.  HIV Type 1 Nef is released from infected cells in CD45(+) microvesicles and is present in the plasma of HIV-infected individuals.

Authors:  A D Raymond; T C Campbell-Sims; M Khan; M Lang; M B Huang; V C Bond; M D Powell
Journal:  AIDS Res Hum Retroviruses       Date:  2010-10-21       Impact factor: 2.205

7.  Genetic characterization of HIV type 1 Nef-induced vesicle secretion.

Authors:  Syed A Ali; Ming-Bo Huang; Patrick E Campbell; William W Roth; Tamika Campbell; Mahfuz Khan; Gale Newman; Francois Villinger; Michael D Powell; Vincent C Bond
Journal:  AIDS Res Hum Retroviruses       Date:  2010-02       Impact factor: 2.205

8.  IL-15 treatment during acute simian immunodeficiency virus (SIV) infection increases viral set point and accelerates disease progression despite the induction of stronger SIV-specific CD8+ T cell responses.

Authors:  Yvonne M Mueller; Duc H Do; Susan R Altork; Carol M Artlett; Edward J Gracely; Christos D Katsetos; Agustin Legido; Francois Villinger; John D Altman; Charles R Brown; Mark G Lewis; Peter D Katsikis
Journal:  J Immunol       Date:  2008-01-01       Impact factor: 5.422

Review 9.  Emerging concepts in the immunopathogenesis of AIDS.

Authors:  Daniel C Douek; Mario Roederer; Richard A Koup
Journal:  Annu Rev Med       Date:  2009       Impact factor: 13.739

10.  The pathogenesis of HIV infection: stupid may not be so dumb after all.

Authors:  Stephen M Smith
Journal:  Retrovirology       Date:  2006-09-08       Impact factor: 4.602

View more
  2 in total

Review 1.  How HIV Nef Proteins Hijack Membrane Traffic To Promote Infection.

Authors:  Cosmo Z Buffalo; Yuichiro Iwamoto; James H Hurley; Xuefeng Ren
Journal:  J Virol       Date:  2019-11-26       Impact factor: 5.103

2.  Secretion modification region-derived peptide blocks exosome release and mediates cell cycle arrest in breast cancer cells.

Authors:  Ming-Bo Huang; Ruben R Gonzalez; James Lillard; Vincent C Bond
Journal:  Oncotarget       Date:  2017-02-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.